Home > Boards > US Listed > Medical - Healthcare > Mylan Inc. (MYL)

http://newsroom.mylan.com/2018-08-08-Statement-from-Mylans-Board-of-Directors... and a strategic

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dangerM Member Profile
 
Followed By 4
Posts 323
Boards Moderated 0
Alias Born 12/22/14
160x600 placeholder
Health-Care Stocks Get a Welcome Respite -- Update Dow Jones News - 10/15/2019 7:58:00 PM
Health-Care Stocks Get a Welcome Respite Dow Jones News - 10/15/2019 12:56:00 PM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 10:22:00 AM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 8:29:00 AM
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission PR Newswire (US) - 9/27/2019 10:25:00 AM
Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer PR Newswire (US) - 9/17/2019 9:30:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 9/3/2019 9:56:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2019 7:30:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 6:31:23 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/6/2019 4:47:29 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/6/2019 4:17:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2019 8:01:23 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 6:48:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 6:31:20 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/31/2019 6:09:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2019 5:30:42 PM
Mylan Deal Caps Pfizer CEO's Remake -- WSJ Dow Jones News - 7/30/2019 3:02:00 AM
WeissLaw LLP Investigates Mylan N.V. PR Newswire (US) - 7/29/2019 8:01:00 PM
Mylan Deal Furthers Pfizer CEO's Bet on Patent-Protected Drugs Dow Jones News - 7/29/2019 6:13:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/29/2019 5:02:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/29/2019 4:17:58 PM
Pfizer to Merge Off-Patent Drug Business With Mylan -- 4th Update Dow Jones News - 7/29/2019 1:52:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2019 12:04:04 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/29/2019 12:01:48 PM
Stocks to Watch: Mylan, Merck, Booz Allen, Cooper Tire, Mohawk Industries and More Dow Jones News - 7/29/2019 9:47:00 AM
dangerM   Wednesday, 08/08/18 04:56:41 PM
Re: DewDiligence post# 120
Post # of 152 
http://newsroom.mylan.com/2018-08-08-Statement-from-Mylans-Board-of-Directors

... and a strategic review.

Quote:

With this said, we believe that the US public markets continue to underappreciate and undervalue the durability, differentiation and strengths of Mylan's global diversified business, especially when compared to our peers around the globe. Therefore, while we will continue to execute on our best-in-class, long-term focused sustainable strategy, the Board has formed a strategic review committee and is actively evaluating a wide range of alternatives to unlock the true value of our one-of-a-kind platform. The Board has not set a timetable for its evaluation of alternatives and there can be no assurance that any alternative will be implemented.





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist